Heterogeneity in Measures of Illness among Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Is Not Explained by Clinical Practice: A Study in Seven U.S. Specialty Clinics. — CFSMEATLAS
Heterogeneity in Measures of Illness among Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Is Not Explained by Clinical Practice: A Study in Seven U.S. Specialty Clinics.
Unger, Elizabeth R, Lin, Jin-Mann S, Chen, Yang et al. · Journal of clinical medicine · 2024 · DOI
Quick Summary
Researchers studied 465 ME/CFS patients across seven specialized clinics in the United States to see if doctors diagnosed and recognized the same disease. They found that while the clinics had similar patients, there was tremendous variation in how sick individual patients were—some had mild symptoms while others were severely affected. This suggests that ME/CFS may naturally come in many different forms, and understanding these differences could help improve research and treatment.
Why It Matters
This study provides evidence that ME/CFS is a real, recognizable condition across different specialty clinics, validating patient experiences and clinical expertise. Understanding that ME/CFS naturally varies widely among patients is crucial for designing better research studies and developing treatments that work for different patient subgroups, rather than treating all ME/CFS as identical.
Observed Findings
Few statistically significant and no clinically significant differences existed between the seven specialty clinics in their patients' standardized ME/CFS symptom measures.
All measured domains (fatigue, functional impairment, post-exertional malaise, sleep, neurocognitive/autonomic symptoms, and pain) showed wide distributions of severity within each clinic sample.
Patients across all clinics demonstrated substantial variation in illness presentation despite being diagnosed with the same condition by experienced clinicians.
Experienced clinicians from different specialty centers consistently diagnosed patients with ME/CFS, suggesting recognition of a common clinical entity.
Inferred Conclusions
Illness heterogeneity appears to be an inherent feature of ME/CFS rather than a result of different diagnostic practices across clinics.
Future ME/CFS research should use visualization methods (scatter plots, histograms) that reveal the full range of patient characteristics rather than summary statistics alone.
Case-control studies that do not account for ME/CFS subgroups or stratify by illness characteristics may fail to replicate and could miss important underlying biological mechanisms.
Remaining Questions
What biological, genetic, or environmental factors explain why ME/CFS manifests so differently among patients?
Do different symptom patterns in ME/CFS represent distinct disease subtypes with different causes, or variations of a single underlying condition?
What This Study Does Not Prove
This study does not identify the causes of ME/CFS heterogeneity or explain why patients vary so widely in their symptoms and severity. It does not test treatments or determine whether different symptom patterns represent distinct biological subtypes versus a single disease with variable manifestation. The cross-sectional design cannot establish how heterogeneity changes over time within individual patients.